Skip to content

Patients › Rehabilitation

扳机指松解术

Post-operative exercises and precautions after trigger finger release, including tendon glides and joint blocking exercises.

Updated Jun 2026
手部屈肌腱示意图,显示指根部腱鞘滑车处有小肿块卡压。
扳机指:屈肌腱上的肿胀卡在手指基部的滑车下方。 Kieran Hirpara 4.0

本页面由机器翻译,尚未经临床医生审核。英文版本为权威版本。

本方案指导您在 Mater Private Hospital Rockhampton 接受 Kieran Hirpara 医生进行的扳机指松解术后的康复过程。本方案说明了预期效果、需遵守的注意事项以及术后锻炼计划:请将此页面或其 PDF 文件带给您的物理治疗师或手部治疗师,以确保您的康复过程协调一致。

如果您对术后伤口有任何疑虑,请联系诊室。通常,拍摄伤口照片并通过电子邮件发送以供审阅会很有帮助。

预期情况

您的伤口护理将在单独说明:请参阅本协议末尾链接的伤口护理页面。

以下练习对于防止伤口愈合过程中肌腱粘连非常重要。在此手术后,您的手指关节有时会变得僵硬。早期预防这种僵硬非常重要,因此建议您用另一只手对您的手指施加牢固、持久的拉伸,尤其是用于伸直手指。这种被动拉伸是安全的,不会影响手术:滑轮装置已经释放,因此内部没有任何东西会被拉伸所扰动。

一旦您的伤口愈合,在进行这些练习前,请对您的手部进行20分钟的热敷。完成练习后,冰敷可能有助于预防炎症。

有时手部或伤口会变得敏感。这是正常的,可以通过立即开始每日脱敏来预防或减轻:在手术后立即开始,轻轻拍打或摩擦伤口(在敷料覆盖下)。这种类型的“感觉反馈”有助于皮肤使触觉和纹理恢复正常。

在最初的48小时内,努力控制肿胀:保持手部抬高,使用冰敷,如果治疗师提供了压缩装置则进行加压,并轻轻“泵动”手指(张开和闭合)以移动肿胀。

一旦疼痛允许,尽早开始用手进行轻度任务(如穿衣、进食等),并逐渐增加强度。不要过度用力:如果活动后您的疼痛或肿胀明显增加,请减轻强度直到手部稳定,然后再逐渐增加。

一旦伤口完全愈合,开始疤痕按摩:在切口上进行牢固的圆形按摩。伤口护理页面提供了更多关于疤痕管理的信息。

证据关于恢复的说法

A1 滑车开放松解术是一项在已发表文献中拥有良好记录且久经考验的手术。手术本身即可纠正卡顿和交锁:一旦滑车被切断,肌腱即可再次自由滑动,且触发症状通常不会复发。在一项涉及近 1,600 例开放松解术的系列研究中,少于 1% 的患者因持续或复发的触发症状需要二次手术,且未发生神经损伤或深部感染 [4]。一项随访超过三年的对比研究同样发现,开放松解术后无复发病例 [5]。

掌部的酸痛感在最初的一到两周内会大幅缓解。在一项对比研究中,开放松解术后疼痛显著减轻的中位时间约为一周 [5]。在掌部用力抓握时出现的轻微压痛、轻度肿胀或手指僵硬可能在随后数周内持续存在。这是正常现象,反映了瘢痕的成熟过程,该过程大约需要三个月 [3];本方案中的脱敏、瘢痕按摩和锻炼计划正是为了管理这一过程而设计的。在上述大型系列研究中,约二十分之一的手指在术后出现有记录的问题,最常见的是暂时性僵硬或瘢痕压痛,经治疗后均可缓解;糖尿病患者的活动度恢复往往较慢,因此锻炼计划对该群体尤为重要 [4]。

已发表的手部治疗方案建议在术后最初几天内开始主动和被动的手指运动及肌腱滑动练习,待伤口愈合后加入瘢痕管理和脱敏训练,并在后期重新引入分级握力强化训练 [2][3],这与本页方案的分阶段方法相同。早期开始锻炼有助于在伤口愈合期间保持肌腱滑动和关节柔韧性。

重返工作的时间取决于工作对手部的要求。在一项对比研究中,约半数患者在开放松解术后两周内重返工作岗位 [5];从事较轻或基于办公桌工作的人员往往能更早恢复,而较重的体力劳动则需等待下方所述的提重和抓握限制解除后方可进行。

一项随机对照试验比较了开放松解术后三个月的督导治疗与自主家庭锻炼计划:在六个月时,两组在整体功能、活动度和疼痛方面相似;握力在督导治疗组恢复得更好;明显从正规治疗中获益的患者是那些术前触发症状持续时间超过十二个月的患者,以及从事家务或较轻工作的人员 [1]。从实际角度来看,执行良好的家庭计划(即本页的锻炼内容)足以帮助大多数患者恢复,而对于术前手指僵硬时间较长或进展缓慢的情况,正规手部治疗能增加额外价值。

注意事项与限制

鼓励手部进行轻度功能性使用,以完成日常生活任务,如自我护理、进食、穿衣、书写和打字。关键限制如下:

  • 术后4周内避免提重物、抓握及承重。
  • 第一周内驾驶受限;待疼痛允许、能完全握拳且能安全控制车辆时方可恢复驾驶。

致您的物理治疗师:

管理

  • 家庭锻炼计划如下方卡片所示:腕关节屈曲/伸展拉伸;远端指间关节(DIP)和近端指间关节(PIP)关节阻挡;肌腱滑动(A系列和B系列)
  • 对手指进行牢固且持续的被动拉伸,尤其是向伸展方向,以早期预防关节僵硬
  • 伤口愈合后,锻炼前对手部热敷20分钟;锻炼后冰敷以预防炎症
  • 术后立即开始每日脱敏训练(在伤口及敷料原位上进行轻柔敲击/摩擦)
  • 术后48小时内的肿胀管理:抬高患肢、冰敷、按需加压、轻柔的手指泵动
  • 随着疼痛允许,分级恢复轻度功能性使用,并监测活动后疼痛/肿胀加重情况
  • 伤口完全愈合后,进行瘢痕按摩(在切口处进行牢固的环形按摩)

注意事项

  • 仅限轻度功能性使用以完成日常生活任务(自我护理、进食、穿衣、书写、打字)
  • 术后4周内禁止提重物、抓握或承重
  • 第一周内驾驶受限;当疼痛允许、能完全握拳且患者能安全控制车辆时方可恢复驾驶

预期里程碑(基于标准,参考已发表方案 [1][2][3])

  • 疼痛在 1–2 周内通过简单镇痛药缓解至舒适水平 [5]
  • 伤口愈合,瘢痕按摩和持续脱敏训练正在进行中,至 2–3 周 [2][3]
  • 约3周内实现手指完全主动屈曲和伸展(完全握拳和完全复合伸展),并通过阻挡和肌腱滑动计划恢复并维持 [2]
  • 在4周提重物/抓握限制解除后,引入分级握力和捏力强化训练(例如使用治疗泥),并逐步过渡到完全功能性使用
  • 若术前触发症状持续超过12个月、患者角色涉及持续轻度/精细手部使用,或关节活动度或握力恢复缓慢,则考虑升级为监督下的手部治疗 [1]

这些是您手册中的锻炼项目,术后开始,并在物理治疗师或手部治疗师的指导下在家继续。

您的练习

用另一只手将手腕向后推,然后向前推,手指保持放松。

Kieran Hirpara 4.0

腕关节屈曲/伸展拉伸

将肘部放在桌面上(或将前臂搁在桌子或扶手椅的边缘),轻轻前后摆动手腕。待感觉更舒适后,用另一只手握住手掌,将手腕向后推(手指放松,指向天花板)——保持15秒;然后反向进行(手指放松,指向地面)——保持15秒。每个方向重复5次。

10 次,4–5 次/天

另一只手在末端关节下方支撑手指,同时手指进行屈曲和伸直运动。

Kieran Hirpara 4.0

远端指间关节阻挡练习

远指间关节(DIP,distal interphalangeal)是手指的末端关节。开始时掌心向上,用另一只手在末端关节下方支撑患手。弯曲并伸直末端关节,每个姿势保持3–5秒。仅对中间关节提供足够的支撑,使其不发生弯曲。在此练习过程中,其他手指移动是可以接受的。

10次,每天4次,每日

另一只手在指骨中部关节下方支撑手指,同时手指进行弯曲和伸直运动。

Kieran Hirpara 4.0

近端指间关节阻挡

近端指间关节(PIP)是手指的中关节。开始时掌心向上,用另一只手在第二关节下方支撑患手。在中关节处弯曲并伸直手指,每个姿势保持3–5秒。其他手指同时移动也是可以的。

10次,每天4次,每日

三种手部姿势:手指完全伸直,然后呈钩状姿势,最后是拇指压在手指上的紧握拳。

Kieran Hirpara 4.0

肌腱滑动 — A 系列

将手置于身前,手腕保持伸直,完全伸直所有手指——您可以用另一只手确保手指达到完全伸展(位置1)。将指尖弯成“钩”状,指关节朝上(位置2)。然后握紧拳头,拇指置于手指之上(位置3)。

5–10 次,每天 2–3 次,每日

三种手部姿势:手指完全伸直,然后仅在最下方指关节处弯曲呈桌面位,最后手指在中间关节处弯曲并触及手掌。

Kieran Hirpara 4.0

腱滑动——B系列

将手置于身前,手腕保持伸直,将所有手指完全伸直——您可以用另一只手确保手指达到完全伸直(位置1)。通过弯曲手指最下方的关节(掌指关节)并保持手指其余部分伸直,使手指呈“桌面”状——确保手腕不要向前下垂(位置2)。然后弯曲手指的中间关节(近端指间关节),使手指触及手掌(位置3)。

5–10 次,每天 2–3 次,每日

将手指完全伸直,然后用另一只手再稍微用力推一下。

Kieran Hirpara 4.0

主动复合伸指

将肘部支撑在桌面上,尽可能伸直手指,然后用另一只手再稍微用力推一下。数到5,然后放松。

10 次,3–4 次/天

手掌平放于桌面,掌心向下,对掌背进行按压按摩。

Kieran Hirpara 4.0

被动复合伸展

将手平放在桌面上,掌心向下。用另一只手在手背施加压力,并向身体方向“按摩”。数到5,然后放松。

10 次,3–4 次/天

将拇指指尖与食指指尖相触并保持。

Kieran Hirpara 4.0

拇指对掌

起始时手指伸直并放松。将拇指指尖与食指指尖相触。保持5秒,然后回到起始位置。

10次,每日3–4次

请仅在Hirpara医生和您的手部治疗师的指导下开始下面这些练习,并严格保持在您被允许的活动范围和限制内。腱滑动系列和阻挡练习可确保已松解的肌腱在腱鞘内自由滑动,防止其在愈合的瘢痕中粘连——这能防止扳机指复发为僵硬。主动和被动复合伸指练习可确保手指完全伸直,拇指对掌练习重建捏力,腕部拉伸练习防止在关注手指时腕部僵硬。手掌瘢痕正上方的压痛在数周内是预期内的。停止任何引起剧烈疼痛的动作。

您的方案之后

本方案由职业治疗学士、认证手部治疗师 Sarah Farrell 共同撰写,并纳入了来自 Extend Rehabilitation 认证手部治疗师 Ruby Doolan 的更新版术后管理指南(2025年4月)。本方案与本诊所的通用康复建议配合使用:请参阅 术后疼痛管理、伤口护理 和 手部治疗基础。关于手术本身,请参阅 扳机指松解术。

康复框架和里程碑还参考了已发表的扳机指松解术康复方案,包括弗吉尼亚大学手部中心和双子城骨科中心的方案,以及开放性扳机指松解术的已发表结局研究,包括一项关于术后康复的随机对照试验(Saito 等,《临床医学杂志》,2023年)和一项大规模不良事件系列研究(Bruijnzeel 等,《手部外科杂志》,2012年)。

参考文献

[1] Saito T, Nakamichi R, Nakahara R, Nishida K, Ozaki T. The effectiveness of rehabilitation after open surgical release for trigger finger: a prospective, randomized, controlled study. J Clin Med. 2023;12(22):7187. https://pmc.ncbi.nlm.nih.gov/articles/PMC10671987/ [2] University of Virginia Hand Center. Trigger Finger Release Guidelines (post-operative therapy protocol). https://med.virginia.edu/orthopaedic-surgery/wp-content/uploads/sites/242/2015/11/Triggerfingerreleaseprotocol.pdf [3] Meletiou SD, Twin Cities Orthopedics. Post-operative Management of Trigger Release (A1 pulley release). https://tcomn.com/wp-content/uploads/2017/10/Trigger-Release-A1.pdf [4] Bruijnzeel H, Neuhaus V, Fostvedt S, Jupiter JB, Mudgal CS, Ring DC. Adverse events of open A1 pulley release for idiopathic trigger finger. J Hand Surg Am. 2012;37(8):1650–1656. https://pubmed.ncbi.nlm.nih.gov/22763058/ [5] Chanthanapodi P, Aodsup S. Comparative results of percutaneous and open surgery for trigger fingers: a propensity score analysis. Front Surg. 2025;12:1509292. https://pmc.ncbi.nlm.nih.gov/articles/PMC11922895/


Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Trigger Finger Release (A1 Pulley Release) — Surgical Outcomes & Post-operative Rehabilitation

Topic scope: (A) the place of surgery in stenosing tenosynovitis (trigger finger/thumb) after failed conservative care (splinting, corticosteroid injection), and (B) post-operative rehabilitation after surgical division of the A1 pulley — open or percutaneous. This is an early-motion pathway: nothing is reconstructed, the catching is mechanically abolished the moment the pulley is divided, and the rehab exists to keep the now-free tendon gliding and the finger joints supple while the wound heals.

Defining principle of the rehab here: A1 pulley release removes the obstruction; it does not create a construct that needs protecting. Once the pulley is divided the flexor tendon glides freely and triggering does not usually recur. So — unlike a tendon repair, and like a carpal-tunnel decompression — the pathway is immediate active motion: full active finger flexion/extension and tendon glides from the first days, oedema and scar care, early light functional use, and a quick return. Most patients need no formal hand therapy at all; supervised therapy is reserved for the minority with pre-existing joint stiffness, long-standing triggering, or slow recovery. The single branch point is whether the finger was already stiff before surgery (long-standing fixed flexion / PIP contracture) — those patients need active therapy to recover motion the release alone cannot restore.


A. WHERE SURGERY SITS IN THE PATHWAY

Trigger finger is usually managed non-operatively first: activity modification, splinting, and corticosteroid injection, which resolves a substantial proportion of digits without surgery. Surgery (A1 pulley release) is reserved for digits that fail injection, recur, or present with a fixed deformity. The corpus contains the comparative evidence underpinning this stepped approach (percutaneous release vs steroid injection; one- vs two-injection regimens; corticosteroid solution choice) — Moderate (RCT). The rehab protocol on the patient page begins after that decision has been made, so this brief concentrates on the surgical and post-surgical evidence.


B. SURGICAL OUTCOMES & RESOLUTION RATES

Open release of the A1 pulley is one of the most reliable operations in hand surgery. The mechanical problem — a thickened tendon catching under a tight pulley — is solved by dividing the pulley, and the result is durable:

  • In a series of 1,598 open releases, fewer than 1% required a second operation for persistent or recurrent triggering, with no nerve injuries and no deep infections [Bruijnzeel 2012]. About one digit in twenty had a documented post-operative problem, almost all minor and self-limiting (transient stiffness, scar tenderness). Strong (large cohort).
  • Recovery of motion is slower in patients with diabetes, reinforcing the value of the exercise program in that group [Bruijnzeel 2012]. Moderate.
  • A propensity-matched comparison with >3 years follow-up found no recurrences after open release, with median time to significant pain reduction of about one week and roughly half of patients back at work within ~2 weeks [Chanthanapodi 2025]. Moderate.

Take-home for rehab: because the operation itself abolishes the triggering, the rehabilitation is not "earning back" a surgical result — it is preventing the two things that can go wrong during healing: tendon adhesion and joint stiffness. Early glide and early extension are the levers.


C. OPEN vs PERCUTANEOUS RELEASE

Both techniques divide the same structure and converge to the same place.

  • A Level I meta-analysis of 8 RCTs (548 patients) found no significant difference between open and percutaneous release in revision, complication, or pain rates — both are appropriate options [Casey 2024, J Hand Surg Am]. Strong (meta-analysis of RCTs).
  • Larger RCT syntheses show percutaneous release confers faster early functional recovery — better short/mid-term Q-DASH, ~12 days earlier return to work, and shorter analgesic use — while long-term function, grip, motion and complication/revision rates are equivalent. Strong.
  • Percutaneous (including ultrasound-guided/sonographically-controlled) technique is supported by multiple corpus series for efficacy and safety, with the main theoretical risks being incomplete release and digital nerve proximity, mitigated by surface landmarks and imaging [corpus percutaneous series]. Moderate.

Rehab implication: the post-operative program is essentially the same for both approaches — early active motion, glides, oedema and scar care. The patient page applies regardless of whether the release was open or percutaneous; percutaneous patients simply tend to be comfortable and back to activity a little sooner.


D. THE ROLE — AND LIMITS — OF POST-OPERATIVE HAND THERAPY

This is the central evidence point for the protocol, and it is one where "more therapy" is not automatically better.

  • A prospective RCT compared 3 months of supervised rehabilitation after open release against a self-directed home exercise program: at six months, overall function, motion and pain were similar between groups. Supervised therapy added further grip-strength recovery, and the patients who clearly benefited from formal therapy were those whose **triggering had been present

    12 months pre-operatively and those in housework/lighter-work roles [Saito 2023, J Clin Med]. Moderate (single RCT).

  • Published surgeon and hand-therapy protocols (e.g. University of Virginia Hand Center; Twin Cities Orthopedics) start active and passive finger motion and tendon glides within the first days, add scar massage and desensitisation once the wound is healed, and reintroduce graded grip strengthening later — precisely the staged structure of the patient page. Consensus.

Bottom line: a well-performed home program carries most patients through. Formal hand therapy is reserved, not routine — escalate it for long-standing pre-operative triggering, pre-existing joint stiffness/contracture, manual or fine-use occupational demands, or slow motion/grip recovery.


E. COMPLICATIONS

Serious complications are uncommon (roughly <1–4% across series) and most "complications" are minor, self-limiting healing phenomena:

  • Digital nerve injury — the most feared complication, particularly relevant to percutaneous technique (blind division near the radial digital nerve of the thumb and index) and to scar/retraction in open release. Rare in experienced hands; transient paraesthesia is more common than true division [corpus complication series]. Moderate.
  • Incomplete release / persistent triggering — failure to fully divide the A1 pulley (or an A2/FDS slip contribution); a recognised cause of revision, more often discussed with percutaneous technique. Moderate.
  • Recurrent triggering — uncommon after adequate open release (<1% reoperation in the 1,598-digit series) [Bruijnzeel 2012]. Strong.
  • Infection — usually superficial; deep infection rare (none in the large open series) [Bruijnzeel 2012]. Strong.
  • Bowstringing — a rare complication from excessive proximal pulley loss (A1 plus encroachment on A2); largely avoided by limiting division to A1 [bowstringing case literature]. Weak (case-level).
  • Stiffness / flexion contracture / "flare" — the commonest self-limiting problem; transient PIP stiffness, scar tenderness and a post-operative inflammatory flare that settle with the motion, desensitisation and scar program. Recovery is slower in diabetes. Moderate. This is the category the rehabilitation program actively targets.

F. PHASED POST-OP TIMELINE (matches the patient protocol)

Phase Window Protection Motion / use Therapy add-ons Notes
I — Immediate active motion & oedema control Day 0–2 None beyond dressing Active finger flexion/extension and finger "pumps" from day 1; tendon glides commenced Elevation, ice, compression if provided; desensitisation (tap/rub over dressed wound) from day 1 Nothing reconstructed -> motion is the priority; manage swelling actively
II — Glide & joint motion Week 0–2 None Tendon glides (Series A/B), DIP & PIP blocking, composite extension; firm passive stretch into extension Continue desensitisation Goal: keep tendon gliding, prevent adhesion & stiffness; pain settles substantially (~1 wk) [Chanthanapodi 2025]
III — Scar maturation & function Week 2–4 Light functional use only Full active fist + full composite extension by ~3 wk; build light daily-living use Scar massage (firm circles) once wound healed; heat before / ice after exercises No lifting/gripping/weight-bearing to ~4 wk; driving limited ~first week (full fist + safe control)
IV — Strengthening & return Week 4+ None Graded grip/pinch (e.g. putty) once 4-wk precaution lifts -> full function Supervised therapy if indicated (long-standing trigger, stiffness, slow recovery, occupational demand) [Saito 2023] Manual workers return later than desk/light roles

Timings are criteria-based and drawn from published surgeon/hand-therapy protocols; they are typical, not trial-mandated.


G. KEY CONTROVERSIES / EVIDENCE QUALITY

  1. Is routine post-op hand therapy necessary? The best available evidence (Saito 2023 RCT) says no for most — home exercise matches supervised therapy on function/pain/motion at six months, with supervised therapy adding grip strength and benefiting a defined subgroup (long-standing trigger, lighter-work roles). The protocol's "therapy reserved, not routine" stance is evidence-aligned. Moderate.
  2. Open vs percutaneous. Equivalent long-term outcomes and safety (Casey 2024 meta-analysis); percutaneous offers faster early recovery. The rehab is the same either way. The live debate is technique-side (nerve safety, completeness of release), not rehab-side. Strong on equivalence.
  3. The rehab protocol structure itself is consensus/expert, built from surgeon patient-guidance documents plus one rehabilitation RCT — there is no large trial dictating exact phase timings.
  4. Diabetes modifies recovery — slower motion recovery and a lower threshold to involve a hand therapist; not a different protocol, a different pace. Moderate.

H. EVIDENCE STRENGTH FLAGS (summary)

  • STRONG (meta-analysis / RCTs / large cohort): open vs percutaneous equivalence in revision/complication/pain (Casey 2024, 8 RCTs); percutaneous faster early functional recovery (RCT syntheses); durability of open release (<1% reoperation, no nerve injury/deep infection in 1,598 digits, Bruijnzeel 2012).
  • MODERATE (single RCT / cohorts): home exercise ~ supervised therapy at 6 months with grip-strength edge for supervised therapy (Saito 2023); percutaneous efficacy/safety series; slower recovery in diabetes; injection-vs- surgery comparative data.
  • WEAK / CONSENSUS: the post-operative rehabilitation protocol structure and exact phase timings (surgeon/hand-therapy patient-guidance documents); bowstringing risk (case-level).

CITATIONS

RAG corpus (180,000+ Orthopaedic articles)

  • Open Versus Percutaneous Fixation of Trigger Finger: Meta-Analysis of Clinical Outcomes. J Hand Surg Am. 2024. DOI: 10.1016/j.jhsa.2024.03.010
  • Complications of Open Trigger Finger Release. J Hand Surg Am. 2010. DOI: 10.1016/j.jhsa.2009.12.040
  • Differential Pulley Release in Trigger Finger: A Prospective, Randomized Clinical Trial. Hand (N Y). 2021. DOI: 10.1177/1558944721994231
  • Percutaneous A1 pulley release vs steroid injection for trigger digit. J Hand Surg Eur. 2010. DOI: 10.1177/1753193410381824
  • Comparative Study of A1 Pulley Release and Ulnar Superficialis Slip Resection in Trigger Finger. J Hand Surg Am. 2022. DOI: 10.1016/j.jhsa.2022.04.021
  • Risk Factors for Requiring Ulnar Superficialis Slip Resection During Trigger Finger Release. J Hand Surg Am. 2024. DOI: 10.1016/j.jhsa.2024.08.013
  • Impact of Flexor Tendon Traction Tenolysis on Clinical Outcomes in Open A1 Pulley Release. J Hand Surg Glob Online. 2024. DOI: 10.1016/j.jhsg.2024.09.010
  • Ultrasound-Assisted Percutaneous Trigger Finger Release: Is It Safe? Hand (N Y). 2008. DOI: 10.1007/s11552-008-9137-8
  • Evaluation of Percutaneous First Annular Pulley Release: Efficacy and Complications. J Hand Surg Am. 2016. DOI: 10.1016/j.jhsa.2016.04.009
  • Sonographically controlled minimally-invasive A1 pulley release using a new guide. BMC Musculoskelet Disord. 2023. DOI: 10.1186/s12891-023-06982-x
  • Percutaneous A1 pulley with corticosteroid injection for trigger finger release. J Orthop Surg Res. 2025. DOI: 10.1186/s13018-025-05776-2
  • A Cost and Efficiency Analysis of the WALANT Technique for the Management of Trigger Finger. Plast Reconstr Surg Glob Open. 2019. DOI: 10.1097/gox.0000000000002509
  • Management of Pediatric Trigger Thumb and Trigger Finger. J Am Acad Orthop Surg. 2012. DOI: 10.5435/jaaos-20-04-206
  • What's New in Hand Surgery. J Bone Joint Surg Am. 2024. DOI: 10.2106/jbjs.23.01343

Trigger finger surgical & rehabilitation literature (URLs)

  • Saito T, et al. The Effectiveness of Rehabilitation after Open Surgical Release for Trigger Finger: A Prospective, Randomized, Controlled Study. J Clin Med. 2023;12(22):7187. https://pmc.ncbi.nlm.nih.gov/articles/PMC10671987/
  • Bruijnzeel H, et al. Adverse Events of Open A1 Pulley Release for Idiopathic Trigger Finger. J Hand Surg Am. 2012;37(8):1650-1656. https://pubmed.ncbi.nlm.nih.gov/22763058/
  • Casey JC, et al. Open Versus Percutaneous Fixation of Trigger Finger: Meta-Analysis of Clinical Outcomes. J Hand Surg Am. 2024;49(6):570-575. https://pubmed.ncbi.nlm.nih.gov/38727666/
  • Chanthanapodi P, Aodsup S. Comparative results of percutaneous and open surgery for trigger fingers: a propensity score analysis. Front Surg. 2025;12:1509292. https://pmc.ncbi.nlm.nih.gov/articles/PMC11922895/
  • Complications of Percutaneous Release of the Trigger Finger. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC6485534/
  • Trigger Finger. StatPearls, NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK459310/
  • Bowstringing as a complication of trigger finger release. J Hand Surg Am. 1988. https://www.jhandsurg.org/article/S0363-5023(88)80097-2/abstract
  • Trigger Finger (patient information). British Society for Surgery of the Hand (BSSH). https://www.bssh.ac.uk/patients/conditions/15/trigger_finger

Published rehab protocols (patient-guidance — basis for the phase structure)

  • University of Virginia Hand Center. Trigger Finger Release Guidelines (post-operative therapy protocol). https://med.virginia.edu/orthopaedic-surgery/wp-content/uploads/sites/242/2015/11/Triggerfingerreleaseprotocol.pdf
  • Meletiou SD, Twin Cities Orthopedics. Post-operative Management of Trigger Release (A1 pulley release). https://tcomn.com/wp-content/uploads/2017/10/Trigger-Release-A1.pdf
  • EmergeOrtho. Trigger Finger Release - Post-operative Instructions. https://emergeortho.com/wp-content/uploads/2022/06/Trigger-Finger-Release.pdf

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.